FBInvestor
Stocks / Abrdn Life Sciences Investor
Institutional Ownership

Abrdn Life Sciences Investor

CUSIP 87911K100SH BEN INTHQLQ1 2026

13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
12.4%
Max % of class reported
Institutional Holders
86
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

19 filings · latest Mar 6, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Mar 6, 2026First Trust Portfolios L.P.13G/A10.1%3.02MSEC
2Feb 23, 2026Saba Capital Management, L.P.13D/A5.0%SEC
3Feb 11, 2026Saba Capital Management, L.P.13D/A5.7%SEC
4Jan 8, 2026Saba Capital Management, L.P.13D/A6.8%SEC
5Nov 24, 2025Saba Capital Management, L.P.13D/A7.9%SEC
6Sep 26, 2025Saba Capital Management, L.P.13D/A9.0%SEC
7Sep 3, 2025Saba Capital Management, L.P.13D/A10.3%SEC
8Apr 28, 2025First Trust Portfolios L.P.13G6.3%1.83MSEC
9Apr 1, 2025Saba Capital Management, L.P.13D/A11.4%SEC
10Jun 3, 2024Saba Capital Management, L.P.13D/A12.4%3.32MSEC

9 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Abrdn Life Sciences Investor.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →